Around 88% of primary care providers managing patients with uncontrolled asthma reported being unfamiliar or only somewhat ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

Phase 3b WAYFINDER data show tezepelumab oral corticosteroid reduction in severe asthma, with nearly 90 percent reaching 5 mg ...

In the 12 months after starting tezepelumab, patients with severe asthma had fewer exacerbations, a lower cumulative oral ...

Tezepelumab reduced exacerbations across all seasons in severe uncontrolled asthma, even among patients with perennial and seasonal allergies.

Use of digital measurement tools to track individual adherence to treatment helped avoid raising doses or adding medications and improved adherence in patients with uncontrolled asthma, the INCA Sun ...

"Regardless of the insurance and of their access to prescription treatment, there are considerable risks associated with being a member of a racial and ethnic community, and increased risk of ...

HealthDay News — For adults with oral corticosteroid (OCS)-dependent severe uncontrolled asthma, tezepelumab can help to reduce OCS use, according to a study published online November 26 in The Lancet ...

Did you know people with uncontrolled asthma go to the emergency room, urgent care, and need to be hospitalized more often for asthma-related emergencies? Uncontrolled asthma can cause your kids to ...

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...

One poster found patients with uncontrolled asthma had improved outcomes after escalating to triple therapy, while the other found a substantial portion of patients adherent to a dual therapy reported ...

Credit: Getty Images. The VOYAGE trial assessed the effect of dupilumab on asthma control in children with type 2 inflammatory asthma phenotype. The following article is a part of conference coverage ...